About
About Noevir Holdings Co., Ltd
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel, body fashion, aircraft and ships, air transportation and pilot training business, etc. The company also provides market research. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Kobe, Japan.
Visit company website
5 years, 5 months ago
Noevir Holdings Co., Ltd is currently in a long term uptrend where the price is trading 13.3% above its 200 day moving average.
From a valuation standpoint, the stock is 223.7% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 3.4.
Noevir Holdings Co., Ltd's total revenue sank by 10.3% to $14B since the same quarter in the previous year.
Its net income has dropped by 20.0% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 4.3% to $3B since the same quarter in the previous year.
Based on the above factors, Noevir Holdings Co., Ltd gets an overall score of 2/5.